Association of smoking with cutaneous manifestations in systemic lupus erythematosus

Arthritis Care and Research

Volumn 65, Issue 8, 2013, Pages 1275-1280

  Bourré Tessier, Josiane ^a   Peschken, Christine A ^b   Bernatsky, Sasha ^a   Joseph, Lawrence ^a   Clarke, Ann E ^a   Fortin, Paul R ^c   Hitchon, Carol ^d   Mittoo, Shikha ^b   Smith, C Douglas ^e   Zummer, Michel ^f   Pope, Janet ^g   Tucker, Lori ^h   Hudson, Marie ^a   Arbillaga, Hector ⁱ   Esdaile, John ^j   Silverman, Earl ^k   Chédeville, Gaelle ^l   Huber, Adam M ^m   Belisle, Patrick ^a   Pineau, Christian A ^a  

^a MCGILL UNIVERSITY   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

^h BC CHILDREN S HOSPITAL   (Canada)

ⁱ Lethbridge Regional Hospital   (Canada)

^j ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

^k HOSPITAL FOR SICK CHILDREN   (Canada)

^l MONTREAL CHILDREN S HOSPITAL   (Canada)

^m IWK HEALTH CENTRE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ALOPECIA; ARTICLE; DISCOID RASH; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALAR RASH; MALE; MOUTH ULCER; PHOTOSENSITIVITY; RASH; RISK ASSESSMENT; SCAR FORMATION; SKIN MANIFESTATION; SKIN ULCER; SLEDAI; SMOKING; SMOKING CESSATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SKIN; SKIN DISEASES; SMOKING;

EID: 84881320544     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21966     Document Type: Article

References (19)

1. Uhlig T, Hagen KB, Kvien TK,. Current tobacco smoking, formal education, and risk of rheumatoid arthritis. J Rheumatol 1999; 26: 47-54.
2. George J, Levy Y, Shoenfeld Y,. Smoking and immunity: an additional player in the mosaic of autoimmunity. Scand J Immunol 1997; 45: 1-6.
3. Ghaussy NO, Sibbitt W Jr, Bankhurst AD, Qualls CR,. Cigarette smoking and disease activity in systemic lupus erythematosus. J Rheumatol 2003; 30: 1215-21.
4. Jewell ML, McCauliffe DP,. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol 2000; 42: 983-7.
5. Rahman P, Gladmann DD, Urowitz MB,. Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J Rheumatol 1998; 25: 1716-9.
6. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
7. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 809-13.
8. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
9. Turchin I, Bernatsky S, Clarke AE, St-Pierre Y, Pineau CA,. Cigarette smoking and cutaneous damage in systemic lupus erythematosus. J Rheumatol 2009; 36: 2691-3.
10. Jolly M, Mikolaitis RA, Block JA, Petri M,. Does cigarette smoking affect disease phenotype in systemic lupus erythematosus? [Abstract]. Arthritis Rheum 2010; 62 Suppl: S319.
11. Ghanim NA, Ghanem A, Nahar E, Esdaile JM, Lacaille D,. Does smoking influence disease manifestations and disease severity in systemic lupus erythematosus? [Absrtract]. Arthritis Rheum 2010; 62 Suppl: S483.
12. Hudson M, Lo E, Lu Y, Hercz D, Baron M, the Canadian Scleroderma Research Group. Cigarette smoking in patients with systemic sclerosis. Arthritis Rheum 2011; 63: 230-8.
13. Hudson M, Lo E, Baron M, Steele R, and the Canadian Scleroderma Research Group. Modeling smoking in systemic sclerosis: a comparison of different statistical approaches. Arthritis Care Res (Hoboken) 2011; 63: 570-8.
14. Sorensen LT, Nielsen HB, Kharazmi A, Gottrup F,. Effect of smoking and abstention on oxidative burst and reactivity of neutrophils and monocytes. Surgery 2004; 136: 1047-53.
15. Freemer MM, King TE Jr, Criswell LA,. Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Ann Rheum Dis 2006; 65: 581-4.
16. Wahie S, Daly AK, Cordell HJ, Goodfield MJ, Jones SK, Lovell CR, et al. Clinical and pharmacogenetic influences on response to hydroxychloroquine in discoid lupus erythematosus: a retrospective cohort study. J Invest Dermatol 2011; 131: 1981-6.
17. Piette EW, Foering KP, Chang AY, Okawa J, Ten Have TR, Feng R, et al. Impact of smoking in cutaneous lupus erythematosus. Arch Dermatol 2012; 148: 317-22.
18. Caraballo RS, Giovino GA, Pechacek TF, Mowery PD,. Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2001; 153: 807-14.
19. Laffondre K, Abrahamowicz M, Xiao Y, Siemiatycki J,. Modelling smoking history using a comprehensive smoking index: application to lung cancer. Statist Med 2006; 25: 4132-46.